We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
351
T. Rowe Price
TROW
$23.8B
$3.76M 0.04%
32,615
-882
-3% -$101K
APP icon
352
Applovin
APP
$107B
$3.76M 0.04%
45,159
+21,495
+91% +$1.67M
HPE icon
353
Hewlett Packard
HPE
$69.5B
$3.76M 0.04%
177,391
-12,736
-7% -$235K
BAH icon
354
Booz Allen Hamilton
BAH
$9.06B
$3.75M 0.04%
24,386
-72
-0.3% -$10.8K
WSM icon
355
Williams-Sonoma
WSM
$27.4B
$3.75M 0.04%
26,580
+4,156
+19% +$619K
KEYS icon
356
Keysight
KEYS
$54.7B
$3.75M 0.04%
27,388
-3,423
-11% -$500K
BRO icon
357
Brown & Brown
BRO
$24.5B
$3.74M 0.04%
41,870
+994
+2% +$86.3K
ANSS
358
DELISTED
Ansys
ANSS
$3.74M 0.04%
11,620
-6,563
-36% -$2.15M
KHC icon
359
Kraft Heinz
KHC
$30.1B
$3.73M 0.04%
115,896
+4,400
+4% +$157K
LPLA icon
360
LPL Financial
LPLA
$29.1B
$3.71M 0.04%
13,301
-135
-1% -$36.6K
LVS icon
361
Las Vegas Sands
LVS
$29.1B
$3.66M 0.04%
82,717
+1,180
+1% +$55.1K
BLDR icon
362
Builders FirstSource
BLDR
$7.2B
$3.65M 0.04%
26,400
+885
+3% +$150K
FTV icon
363
Fortive
FTV
$17.9B
$3.65M 0.04%
65,407
-78
-0.1% -$4.53K
WDC icon
364
Western Digital
WDC
$167B
$3.65M 0.04%
63,736
+3,533
+6% +$196K
MOH icon
365
Molina Healthcare
MOH
$10.5B
$3.64M 0.04%
12,236
+337
+3% +$114K
EXPE icon
366
Expedia Group
EXPE
$39.2B
$3.64M 0.04%
28,870
+2,309
+9% +$285K
MTB icon
367
M&T Bank
MTB
$34.4B
$3.61M 0.04%
23,870
-56
-0.2% -$8.18K
QVMT
368
Invesco S&P 500 Concentrated QVM ETF
QVMT
$134M
$3.61M 0.04%
88,700
ENTG icon
369
Entegris
ENTG
$20.5B
$3.61M 0.04%
26,627
+13,536
+103% +$1.79M
WRK
370
DELISTED
WestRock Company
WRK
$3.6M 0.04%
71,588
-206
-0.3% -$10.4K
GRMN
371
Garmin
GRMN
$55.4B
$3.58M 0.04%
21,986
-18
-0.1% -$2.83K
MELI icon
372
Mercado Libre
MELI
$99.6B
$3.56M 0.04%
2,167
+38
+2% +$60K
LYB icon
373
LyondellBasell Industries
LYB
$20.4B
$3.55M 0.04%
37,067
-190
-0.5% -$18.9K
FERG icon
374
Ferguson
FERG
$44.3B
$3.51M 0.04%
18,105
+147
+0.8% +$30.8K
TTWO icon
375
Take-Two Interactive
TTWO
$44.6B
$3.5M 0.04%
22,521
-897
-4% -$136K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.